Ozempic
-
healthHealth Canada Approves Second Generic Semaglutide from Apotex
Health Canada clears Apotex's generic semaglutide for type 2 diabetes, expanding access to alternatives for brand-name drugs like Ozempic.
-
healthPeptide Boom Under Scrutiny: Doctors Issue Warnings on the 'Wild West' Market
Inside the rapidly growing peptide market. Doctors explain the risks and the crucial dos and don'ts as FDA weighs easing restrictions.
-
healthIndia's Generic Drugmakers Disrupt Weight Loss Market with Cheaper Semaglutide
Indian pharma companies launch generic semaglutide, slashing costs up to 70% and aiming to supply the global market.
-
healthCanada Approves First Generic Semaglutide, Paving Way for Lower Costs
Health Canada greenlights the first generic semaglutide, akin to Ozempic, potentially slashing treatment costs for millions of Canadians.
-
healthWeight-Loss Drugs Show Potential in Reducing Alzheimer's Protein Buildup
A major review suggests popular GLP-1 weight-loss drugs may help limit the molecular hallmarks of Alzheimer's disease, reducing amyloid-beta and tau proteins in preclinical studies.
-
healthHealth Canada Approves First Generic Ozempic Amid Cost Concerns
Health Canada has approved the first generic version of Ozempic, a move expected to significantly reduce costs for Type 2 diabetes patients and potentially for weight loss treatments.
-
healthGenetic Variants May Explain Why GLP-1 Drugs Fail for Some Patients
New research suggests specific genetic variations in the PAM gene could be the reason why GLP-1 medications like Ozempic are ineffective for approximately 10% of individuals with type 2 diabetes.
-
healthNew Study Reveals Unreported Side Effects of Popular Weight-Loss Drugs
A University of Pennsylvania study analyzing Reddit posts uncovers potential new side effects of GLP-1 agonists like Ozempic and Mounjaro, beyond common gastrointestinal issues.